institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Vivasure Submits PMA For Vascular Closure System To FDA - Data Intelligence

Summary by Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.
The system is a fully absorbable, sutureless closure device for use after percutaneous cardiovascular procedures. Credit: Max Acronym / Shutterstock. Irish company Vivasure Medical has submitted an application seeking premarket approval (PMA) from the US Food and Drug Administration (FDA) for its PerQseal Elite vascular closure system intended for arterial procedures. This submission is supported by the outcomes of the PATCH study and the system…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cardiovascular News broke the news in on Tuesday, June 24, 2025.
Sources are mostly out of (0)

Similar News Topics